烷化剂化疗后卵巢显示急性卵泡激活并揭示卵泡丢失机制
发现烷化剂组原始卵泡显著丢失、生长卵泡绝对数显著增加,且生长卵泡数与化疗后时间呈负相关,提示急性卵泡激活是化疗诱导卵泡丢失的病理机制之一。
要点
- 烷化剂化疗后卵巢原始卵泡显著丢失且生长卵泡增多。
- 生长卵泡数与化疗后时间呈负相关,提示急性激活。
- 非烷化剂化疗未见上述卵泡丢失或激活表现。
核心结论
- 烷化剂化疗后患者卵巢内发生卵泡激活,可能是化疗诱导卵泡丢失的病理机制之一。
主要发现
- 烷化剂组卵巢原始卵泡显著丢失,生长卵泡绝对数显著增加,且生长卵泡数与化疗后时间呈负相关。
- 超短时间间隔(4-12天)内,烷化剂组原始卵泡FOXO3A核定位减少,非烷化剂组无此变化。
- 超短时间间隔内,烷化剂或非烷化剂化疗后原始卵泡中cleaved caspase-3表达均未增加。
- 仅在卵泡丢失发生后(4-6个月)的烷化剂组卵巢中观察到显著间质纤维化和新生血管形成。
临床怎么用
- 对于接受烷化剂化疗的年轻女性,应意识到急性卵泡激活可能加速卵巢储备耗竭,生育力保存咨询需考虑此机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate mechanisms of primordial follicle (PMF) loss in vivo in human ovaries shortly after alkylating agent (AA) chemotherapy. DESIGN: Cohort study. SETTING: Tertiary university medical center. PATIENT(S): Ninety-six women aged 15-39 years who underwent ovarian tissue cryopreservation for fertility preservation. INTERVENTION(S): Fresh ovarian tissue samples were harvested from women treated with AA (n = 24) or non-AA (n = 24) chemotherapy <6 months after treatment and age-matched untreated women (n = 48). MAIN OUTCOME MEASURE(S): Differential follicle counts, time from chemotherapy exposure, immunostaining for apoptosis (cleaved caspase-3) and FOXO3A on tissue harvested within ultrashort time intervals (4-12 days), collagen (Sirius red) and neovascularization (CD34). RESULT(S): AA-treated ovaries had significant loss of PMFs, and significant increase in absolute numbers of growing follicles compared with untreated control ovaries. The number of growing follicles was inversely correlated with time from chemotherapy. Representative staining for FOXO3A observed decreased nuclear localization in PMF oocytes in AA-treated ovaries removed within the ultrashort time interval compared with untreated ovaries. Neither significant loss of PMFs, increase in growing follicles, nor decrease in nuclear FOXO3A were observed in non-AA-treated ovaries. No increased expression of cleaved caspase-3 was seen in PMFs within the ultrashort time interval after AA or non-AA chemotherapy. Significant stromal fibrosis and neovascularization were observed in AA-treated ovaries only after follicle loss had already occurred (4-6 months). CONCLUSION(S): Follicle activation occurs in vivo in ovaries of patients treated with AA, indicating a pathologic mechanism which may contribute to chemotherapy-induced follicle loss.
引用
- Shai D, Aviel-Ronen S, Spector I, et al. Ovaries of patients recently treated with alkylating agent chemotherapy indicate the presence of acute follicle activation, elucidating its role among other proposed mechanisms of follicle loss. Fertil Steril. 2021. PMID: 33485607. doi:10.1016/j.fertnstert.2020.11.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。